Target intelligence / Profile preview

Fibrinolytic enzyme

Molecular classification
Enzyme, Protease (peptidase), Serine protease (many forms), Other protease types (e.g., cysteine protease, metalloprotease, aspartic protease, threonine protease)
01

Overview

Fibrinolytic enzymes are a broad class of proteolytic enzymes that catalyze the degradation of fibrin, the primary protein component of blood clots. Members include both endogenous enzymes (such as plasmin and its activators, tissue plasminogen activator and urokinase) and exogenous enzymes obtained from bacteria (streptokinase, staphylokinase), animals (lumbrokinase), and plants (nattokinase, bromelain, serrapeptase). These enzymes are used therapeutically to dissolve blood clots in a range of cardiovascular conditions, including myocardial infarction, stroke, and pulmonary embolism. Their mechanisms involve either direct proteolysis of fibrin or activation of the body's own plasminogen system; selectivity and safety profiles vary among agents. Excessive activation of fibrinolysis can lead to serious bleeding events, representing the main clinical safety concern. Notes on correctness: "Fibrinolytic enzymes" refers to a class/category, not a unique molecular target, and may group together distinct proteins such as plasmin, tPA, and a range of microbial and plant-derived enzymes. Individual drugs and biomarkers often act on or mimic one principal endogenous enzyme (e.g., plasmin), not the entire class. This imprecision makes "Fibrinolytic enzymes" too generic as a single drug target entry. For structured pharmacological databases, each specific enzyme (e.g., "Tissue plasminogen activator", "Streptokinase", "Nattokinase") should be entered separately, with "Fibrinolytic enzyme" serving as a broader functional category, not a canonical target.

Other names
Plasminplasminogen activatorthrombolytic enzymeclot-dissolving enzymelumbrokinasenattokinasestreptokinaseurokinasetissue plasminogen activator (tPA)staphylokinaseserrapeptasebromelainpapaindesmoteplase
02

Mechanism of action

Catalysis of fibrin degradation (direct breakdown of fibrin mesh); Activation of plasminogen to plasmin (indirectly increasing endogenous fibrinolysis); Enhancement of tissue plasminogen activator (tPA) activity; Non-selective proteolysis (for some agents)

03

Biological functions

Fibrin degradationThrombus (clot) dissolutionTissue remodelingBlood flow maintenanceRegulation of hemostasis(Secondary roles) Immune response, anti-inflammation, modulation of extracellular matrix
04

Disease associations

Cardiovascular disease (especially thrombosis, myocardial infarction, stroke, deep vein thrombosis, pulmonary embolism)InflammationNeurodegenerative disease (possible)Cancer progression (some evidence via tissue remodeling)Infection (limited context)
05

Safety considerations

Excessive bleeding/hemorrhage (primary concern)Allergic reaction (notably with streptokinase)Hypotension (with some agents)Short half-life and risk of re-occlusion (with some drugs)Antibody development (streptokinase, repeated exposure)Off-target proteolysis (non-fibrin specific agents, e.g., nattokinase)
06

Interacting drugs

Tissue plasminogen activator (tPA) / recombinant tPA (alteplase)

8 more in the full profile.

07

Biomarkers

D-dimer (fibrin degradation product)Fibrin degradation products (general)Plasmin-antiplasmin complexesBlood clotting times (PT, PTT, INR)

Beyond the preview

Go deeper on Fibrinolytic enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibrinolytic enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call